Aridis Pharmaceuticals receives Nasdaq notice on late filing of Form 10-K
PremiumThe FlyAridis Pharmaceuticals receives Nasdaq notice on late filing of Form 10-K
2y ago
Aridis Pharmaceuticals (ARDS) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Aridis Pharmaceuticals (ARDS) Q4 Earnings Cheat Sheet
2y ago
Aridis Pharmaceuticals announces $2.28M registered direct offering
Premium
The Fly
Aridis Pharmaceuticals announces $2.28M registered direct offering
2y ago
Aridis drops after endpoint in AR-301–002 study not statistically significant
PremiumThe FlyAridis drops after endpoint in AR-301–002 study not statistically significant
2y ago
Aridis: No statistical significance in primary endpoint in AR-301–002 study
Premium
The Fly
Aridis: No statistical significance in primary endpoint in AR-301–002 study
2y ago
Aridis to present AR 501 Phase 2 trial update for CF treatment at KOL
Premium
The Fly
Aridis to present AR 501 Phase 2 trial update for CF treatment at KOL
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100